@FiercePharma: Sun Pharmaceutical's Shanghvi drops from top spot in Forbes India rich list. FiercePharmaAsia story | Follow @FiercePharma
@CarlyHFierce: ICYMI: Merck KGaA counts on Latin America to power consumer-health future. Article | Follow @CarlyHFierce
> The European Medicines Agency's (EMA) management board has nominated Guido Rasi as its executive director. Release
> The FDA has approved Allergan's Juvederm Ultra XC for use in the lips. Release
> Hi-Tech Pharmaceuticals has filed a lawsuit against Dynamic Sports Nutrition over allegations of Racketeer Influenced and Corrupt Organizations (RICO), trademark infringement and deceptive advertising. Release
> Association of the British Pharmaceutical Industry (ABPI) CEO Stephen Whitehead has left the organization. Report
> Early medication-fill patterns can predict future adherence, a study from the CVS Health Research Institute and Brigham and Women's Hospital says. More
> Bayer's plastics business whittled down its IPO's planned share sale to €1.5 billion ($1.7 billion) from €2.5 billion, in part because of the impact of the emissions scandal surrounding Volkswagen, a major customer. Report
Medical Device News
@FierceMedDev: From FierceDrugDelivery: Intarcia buys Phoundry in search of additional diabetes drugs for its subdermal drug pump. Story | Follow @FierceMedDev
@VarunSaxena2: Study: Oraya radiation tech reduces need for eye injections in AMD patients. Article | Follow @VarunSaxena2
@EmilyWFierce: ICYMI from FiercePharma: New Hampshire AG launches investigation into opioid marketing. Article | Follow @EmilyWFierce
> Neuravi ready to take on Medtronic, Stryker in burgeoning market for devices to fight stroke. More
Biotech News
@FierceBiotech: Fierce's coverage of the Martin Shkreli saga. More | Follow @FierceBiotech
@JohnCFierce: Ladies and gentlemen, the 2015 Fierce 15. Special report | Follow @JohnCFierce
> Sarepta gets creative in bolstering its case for quick eteplirsen approval. Report
> Genentech embraces Arvinas with $300M tie-up on protein degradation. Story
> Facing a crisis, Xoma buys time with a $517M Novartis deal. Article
Vaccines News
> Novavax's RSV jab protects infants in PhII, nets $89M Gates Foundation grant. Article
> Advaxis targets HER2 cancers with first-in-human vaccine trial. Story
> BiondVax, EU's UNISEC team up for universal flu jab PhIIb. More
> PRA Health joins with clinical research network to improve vaccine studies. Item
> NewLink wins $26.1M in government funding to advance Ebola vaccine. Report
CRO News
> Frontage doubles its bioanalytics space. Item
> Accelovance snags another Big Pharma cancer vet to boost its onco profile. Report
> PRA partners up to accelerate vaccine R&D. More
> Patheon rebrands with a $100M IPO in the works. Story
> Chiltern expands in diabetes after a big buyout. Article
Pharma Manufacturing News
> Siegfried completes $302M deal for BASF API plants. News
> EPA presents Pfizer with $194M bill to cleanup former American Cyanide site. Report
> Abbott said to expand manufacturing, other operations in India. Story
> Will a desktop device that synthesizes lidocaine revolutionize pharma manufacturing? More
> Hovione set to expand its NJ facility and add new spray dryer. Article
Pharma Asia News
> China slaps Fosun Pharma unit with small fine for anti-monopoly violations. News
> Singapore's Biosensors launches sales of BMX-J stent in key Japan market. More
> Australia's Paranta Biosciences raises A$7M for PhI of cystic fibrosis candidate. Report
> China biotech CARsgen inks deal with Shanghai Cancer Institute on candidate focus. Story
> MSF campaigns at UN summit meeting to ease pressure on India's drug IP policies. Article
And Finally... Deleted quality tests in China have put the FDA on notice. Report